• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

January 3, 2018

Trending News Today: Type 2 Diabetes More Common Among African Americans

Author(s):

Laurie Toich, Associate Editor

Top news of the day from across the health care landscape.

Type 2 diabetes is nearly twice as common among African Americans compared with whites, with obesity as a driving factor, according to The New York Times. A new JAMA report examined the health of 4251 individuals over an average of 25 years. The researchers discovered that black men were 67% more likely and black women were nearly 3 times as likely to develop diabetes as their white counterparts, according to the article. After controlling for numerous modifiable risk factors, the racial disparities resolved and they found that obesity was a major contributor to diabetes risk, the Times reported.

Alex Azar, President Donald Trump’s nominee for Health and Human Services Secretary, will face a confirmation hearing next week, according to The Hill. The meeting before the Senate Finance Committee will give Azar the chance to discuss his plans to address the pitfalls of the Affordable Care Act, while preserving Medicare and Medicaid, according to the article. This is the final step in vetting Azar in hopes that he could address the health care challenges currently facing Americans.

Top hospital groups are planning to move forward in a fight against proposed changes to the 340B program, The Hill reported. The group’s lawsuit was dismissed last week by a US District judge who ruled that it was premature. Following the implementation of $1.6 billion in cuts to hospitals participating in the program, hospital groups and lobbyists are calling on Congress to reverse the ruling in the funding bill or enact another must-pass bill, according to the article.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Pharmacist and doctor -- Image credit: ake1150 | stock.adobe.com
Pharmacist and patient -- Image credit: Zamrznuti tonovi | stock.adobe.com
Type 1 diabetes -- Image credit: daniiD | stock.adobe.com
Related Content
Advertisement
3d rendered illustration of heart attack and heart disease 3D illustration - Image credit: santoelia | stock.adobe.com
August 30th 2025

Updated Diabetes Guidelines Prioritize SGLT-2 and GLP-1 Medications to Reduce Cardiovascular, Kidney Risk

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Limited Series: Celebrity Endorsements in Ozempic
August 30th 2025

Pharmacy Focus: Limited Series: Celebrity Endorsements in Ozempic

Ashley Gallagher, Editor
Culturally Tailored Education Empowers Patients With Type 1 Diabetes
August 30th 2025

Culturally Tailored Education Empowers Patients With Type 1 Diabetes

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Turning the Tide On Obesity - Episode 2
August 30th 2025

Pharmacy Focus: Turning the Tide On Obesity - Episode 2

Prague,Czech republic-June 17 2024: Jardiance box of medication with Empagliflozin active substance by Boehringer Ingelheim,used for treatment of Type 2 diabetes,Heart failure,Hyperglycemia - Image credit: Semi | stock.adobe.com
August 30th 2025

A Few Key Points Can Guide SGLT2 Inhibitor Management

Jeannette Y. Wick, MBA, RPh, FASCP
Antidiabetic Medication Combinations Have Varying Effects on Diabetic Kidney Disease Progression
August 30th 2025

Antidiabetic Medication Combinations Have Varying Effects on Diabetic Kidney Disease Progression

Samar Nicolas, PharmD, RPh, CPPS Abir O. Kanaan, PharmD, RPh
Related Content
Advertisement
3d rendered illustration of heart attack and heart disease 3D illustration - Image credit: santoelia | stock.adobe.com
August 30th 2025

Updated Diabetes Guidelines Prioritize SGLT-2 and GLP-1 Medications to Reduce Cardiovascular, Kidney Risk

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Limited Series: Celebrity Endorsements in Ozempic
August 30th 2025

Pharmacy Focus: Limited Series: Celebrity Endorsements in Ozempic

Ashley Gallagher, Editor
Culturally Tailored Education Empowers Patients With Type 1 Diabetes
August 30th 2025

Culturally Tailored Education Empowers Patients With Type 1 Diabetes

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Turning the Tide On Obesity - Episode 2
August 30th 2025

Pharmacy Focus: Turning the Tide On Obesity - Episode 2

Prague,Czech republic-June 17 2024: Jardiance box of medication with Empagliflozin active substance by Boehringer Ingelheim,used for treatment of Type 2 diabetes,Heart failure,Hyperglycemia - Image credit: Semi | stock.adobe.com
August 30th 2025

A Few Key Points Can Guide SGLT2 Inhibitor Management

Jeannette Y. Wick, MBA, RPh, FASCP
Antidiabetic Medication Combinations Have Varying Effects on Diabetic Kidney Disease Progression
August 30th 2025

Antidiabetic Medication Combinations Have Varying Effects on Diabetic Kidney Disease Progression

Samar Nicolas, PharmD, RPh, CPPS Abir O. Kanaan, PharmD, RPh
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.